Luminex LIAISON PLEX Gram-Negative Blood Culture Assay Recalled for Diagnostic Delay
Luminex Corporation is recalling LIAISON PLEX Gram-Negative Blood Culture Assay cartridges because updated instructions recommend repeat testing to prevent incorrect or delayed diagnosis of bloodstream infections.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as Class II and involves a diagnostic delay hazard that may contribute to incorrect or delayed diagnosis of bloodstream infection. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Luminex Corporation is recalling 30,168 test cartridges (2,514 Kits) of the LIAISON PLEX Gram-Negative Blood Culture Assay, Catalog No. 20-005-303. The recall was initiated because the Instructions for Use have been updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained.
The issue may contribute to incorrect or delayed diagnosis of bloodstream infection. The affected product was distributed nationwide in the United States. No out-of-state distribution is reported.
The source text does not report any illnesses, injuries, or deaths associated with this recall. Users should follow the updated instructions for use, which recommend repeat testing for positive family-level only results.
The recalled product
- Product
- LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303
- Manufacturer
- Luminex Corporation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots UDI-DI pending
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Luminex Corporation
See all →- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighVerigene Gram Positive Blood Culture Test Recalled for Defective Cartridges
FDA (Devices) · 2024-08-14
- ModerateLuminex VERIGENE BC-GP Utility Trays Recalled Due to Potential Defects
FDA (Devices) · 2023-12-13
- HighVerigene nucleic acid test kits recalled for rare false-negative results
FDA (Devices) · 2023-07-05
- HighVERIGENE Clostridium difficile Nucleic Acid Test May Give False-Negative Results
FDA (Devices) · 2023-07-05
Same hazard · diagnostic delay
See all →- ModerateCulture media quality control kits contain the wrong bacterial organism
FDA (Devices) · 2025-07-23
- HighBeckman Coulter Sample Probes with Defective Tips Clinical Chemistry
FDA (Devices) · 2025-06-11
- HighDxI 9000 Access Immunoassay Analyzer Encoder Wheel Misalignment
FDA (Devices) · 2025-03-26
- ModerateBeckman Coulter Urine Chemistry Controls May Produce False Positive Results
FDA (Devices) · 2024-10-23
- HighMRI Diagnostic Device Loose Screws May Block Patient Tabletop
FDA (Devices) · 2024-10-02
Similar recalls
- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighLuminex Recalls Verigene Blood Culture Gram-Positive Nucleic Acid Kits
FDA (Devices) · 2018-11-21
- HighVerigene Gram Positive Blood Culture Test Recalled for Defective Cartridges
FDA (Devices) · 2024-08-14
- HighVerigene Gram Negative Blood Culture Test Recalled for Risk of False-Negative Results
FDA (Devices) · 2021-07-14
- HighVerigene Gram Negative Blood Culture Test Recalled for Potential False-Negative Results
FDA (Devices) · 2021-07-14
- HighVerigene Gram-Positive Blood Culture Test Recalled for Potential False-Negative Results
FDA (Devices) · 2021-07-14